Investigating the effect of empagliflozin on blood sugar control, edema, electrolytes and hypertensio
Phase 3
Recruiting
- Conditions
- Diabetes.Type 2 diabetes mellitus
- Registration Number
- IRCT20130812014333N217
- Lead Sponsor
- Kermanshah University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 134
Inclusion Criteria
Informed consent
Hemodialysis patients with a history of diabetes
Exclusion Criteria
History of allergy to empagliflozin
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method